HIV self-testing with digital supports as the new paradigm: A systematic review of global evidence (2010-2021).
Digital
HIV
Intervention
Mhealth
Online
Self-testing
Journal
EClinicalMedicine
ISSN: 2589-5370
Titre abrégé: EClinicalMedicine
Pays: England
ID NLM: 101733727
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
27
04
2021
revised:
06
07
2021
accepted:
15
07
2021
entrez:
25
8
2021
pubmed:
26
8
2021
medline:
26
8
2021
Statut:
epublish
Résumé
HIV self-testing (HIVST) is recommended by the WHO as an innovative strategy to reach UNAIDS targets to end HIV by 2030. HIVST with digital supports is defined as the use of digital interventions (e.g., website-based, social media, mobile HIVST applications (apps), text messaging (SMS), digital vending machines (digital VMs)) to improve the efficiency and impact of HIVST. HIVST deployment and integration in health services is an emerging priority. We conducted a systematic review aiming to close the gap in evidence that summarizes the impact of digitally supported HIVST and to inform policy recommendations. We searched PubMed and Embase for articles and abstracts on HIVST with digital supports published during the period February 1st, 2010 to June 15th, 2021, following Cochrane guidelines and PRISMA methodology. We assessed feasibility, acceptability, preference, and impact outcomes across all populations and study designs. Metrics reported were willingness to use HIVST, preferences for HIVST delivery, proportion of first-time testers, HIVST uptake, HIVST kit return rate, and linkage to care. Heterogeneity of the interventions and reported metrics precluded us from conducting a meta-analysis. 46 studies were narratively synthesized, of which 72% were observational and 28% were RCTs. Half of all studies (54%, 25/46) assessed web-based innovations (e.g., study websites, videos, chatbots), followed by social media (26%, 12/46), HIVST-specific apps (7%, 3/46), SMS (9%, 4/46), and digital VMs (4%, 2/46). Web-based innovations were found to be acceptable (77-97%), preferred over in-person and hybrid options by more first-time testers (47-48%), highly feasible (93-95%), and were overall effective in supporting linkage to care (53-100%). Social media and app-based innovations also had high acceptability (87-95%) and linkage to care proportions (80-100%). SMS innovations increased kit return rates (54-94%) and HIVST uptake among hard-to-reach groups. Finally, digital VMs were highly acceptable (54-93%), and HIVST uptake was six times greater when using digital VMs compared to distribution by community workers. HIVST with digital supports was deemed feasible, acceptable, preferable, and was shown to increase uptake, engage first-time testers and hard-to-reach populations, and successfully link participants to treatment. Findings pave the way for greater use of HIVST interventions with digital supports globally.
Sections du résumé
BACKGROUND
BACKGROUND
HIV self-testing (HIVST) is recommended by the WHO as an innovative strategy to reach UNAIDS targets to end HIV by 2030. HIVST with digital supports is defined as the use of digital interventions (e.g., website-based, social media, mobile HIVST applications (apps), text messaging (SMS), digital vending machines (digital VMs)) to improve the efficiency and impact of HIVST. HIVST deployment and integration in health services is an emerging priority. We conducted a systematic review aiming to close the gap in evidence that summarizes the impact of digitally supported HIVST and to inform policy recommendations.
METHODS
METHODS
We searched PubMed and Embase for articles and abstracts on HIVST with digital supports published during the period February 1st, 2010 to June 15th, 2021, following Cochrane guidelines and PRISMA methodology. We assessed feasibility, acceptability, preference, and impact outcomes across all populations and study designs. Metrics reported were willingness to use HIVST, preferences for HIVST delivery, proportion of first-time testers, HIVST uptake, HIVST kit return rate, and linkage to care. Heterogeneity of the interventions and reported metrics precluded us from conducting a meta-analysis.
FINDINGS
RESULTS
46 studies were narratively synthesized, of which 72% were observational and 28% were RCTs. Half of all studies (54%, 25/46) assessed web-based innovations (e.g., study websites, videos, chatbots), followed by social media (26%, 12/46), HIVST-specific apps (7%, 3/46), SMS (9%, 4/46), and digital VMs (4%, 2/46). Web-based innovations were found to be acceptable (77-97%), preferred over in-person and hybrid options by more first-time testers (47-48%), highly feasible (93-95%), and were overall effective in supporting linkage to care (53-100%). Social media and app-based innovations also had high acceptability (87-95%) and linkage to care proportions (80-100%). SMS innovations increased kit return rates (54-94%) and HIVST uptake among hard-to-reach groups. Finally, digital VMs were highly acceptable (54-93%), and HIVST uptake was six times greater when using digital VMs compared to distribution by community workers.
INTERPRETATION
CONCLUSIONS
HIVST with digital supports was deemed feasible, acceptable, preferable, and was shown to increase uptake, engage first-time testers and hard-to-reach populations, and successfully link participants to treatment. Findings pave the way for greater use of HIVST interventions with digital supports globally.
Identifiants
pubmed: 34430835
doi: 10.1016/j.eclinm.2021.101059
pii: S2589-5370(21)00339-4
pmc: PMC8367787
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101059Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
Dr Pant Pai reports a copyright for HIVSmart! (an open access mobile application), issued by McGill University (#1105598) in 2013, and co-owned by Grand Challenges Canada and McGill University. The other authors have no conflicts of interest to declare.
Références
AIDS. 2018 Jan 28;32(3):371-381
pubmed: 29194120
AIDS Behav. 2018 Jan;22(1):190-201
pubmed: 28831616
AIDS Behav. 2020 May;24(5):1517-1530
pubmed: 31760536
J Med Internet Res. 2019 Aug 01;21(8):e14145
pubmed: 31373276
Sex Transm Infect. 2016 Sep;92(6):470-3
pubmed: 27221475
Braz J Infect Dis. 2021 Jan-Feb;25(1):101037
pubmed: 33285137
AIDS Educ Prev. 2016 Aug;28(4):341-50
pubmed: 27427928
Sex Transm Dis. 2021 Mar 1;48(3):e41-e44
pubmed: 32842048
AIDS Care. 2017 Dec;29(12):1499-1503
pubmed: 28393612
Curr HIV/AIDS Rep. 2020 Aug;17(4):269-280
pubmed: 32507984
JMIR Mhealth Uhealth. 2017 Mar 09;5(3):e26
pubmed: 28279949
JMIR Public Health Surveill. 2017 Jul 07;3(3):e45
pubmed: 28687531
AIDS Behav. 2021 Jan;25(1):167-170
pubmed: 32594272
South Afr J HIV Med. 2020 Jun 30;21(1):1088
pubmed: 32670629
Int J STD AIDS. 2021 May 12;:9564624211014729
pubmed: 33978539
Disaster Med Public Health Prep. 2020 Apr 08;:1-8
pubmed: 32264992
BMJ Open. 2017 Nov 3;7(11):e017604
pubmed: 29101138
HIV Med. 2020 May;21(5):322-333
pubmed: 31849177
Mhealth. 2021 Apr 20;7:26
pubmed: 33898595
HIV Med. 2017 May;18(5):376-382
pubmed: 27601301
Int J STD AIDS. 2020 Feb;31(2):158-165
pubmed: 31969061
PLoS One. 2014 Jul 22;9(7):e102812
pubmed: 25051160
BMC Public Health. 2019 Jan 3;19(1):7
pubmed: 30606161
BMC Public Health. 2020 Jun 12;20(1):911
pubmed: 32532280
PLoS Med. 2018 Aug 28;15(8):e1002645
pubmed: 30153265
Sex Transm Infect. 2019 Dec;95(8):557-561
pubmed: 31101723
J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25118
pubmed: 30033644
Clin Infect Dis. 2020 Jun 26;:
pubmed: 32588883
PLoS One. 2019 Jul 17;14(7):e0219826
pubmed: 31314764
NPJ Digit Med. 2018 Sep 20;1:48
pubmed: 31304327
BMJ. 2012 Jul 05;345:e4636
pubmed: 22767643
Sex Health. 2016 May 23;:
pubmed: 27209076
JAMA Intern Med. 2020 Jan 1;180(1):117-125
pubmed: 31738378
J Acquir Immune Defic Syndr. 2020 Aug 15;84(5):453-462
pubmed: 32692103
Int J Environ Res Public Health. 2021 Jan 15;18(2):
pubmed: 33467770
Sex Transm Infect. 2020 May;96(3):173-176
pubmed: 31189548
Enferm Infecc Microbiol Clin (Engl Ed). 2021 Jan;39(1):3-8
pubmed: 32151468
Sex Transm Infect. 2018 Aug;94(5):377-383
pubmed: 29437985
HIV Med. 2018 Oct;19(9):585-596
pubmed: 29963766
J Med Internet Res. 2020 Jul 28;22(7):e14230
pubmed: 32720902
J Virus Erad. 2017 Jan 1;3(1):15-23
pubmed: 28275454
BMC Infect Dis. 2019 Aug 8;19(1):699
pubmed: 31391003
JMIR Mhealth Uhealth. 2021 Apr 13;9(4):e19511
pubmed: 33847597
J Med Internet Res. 2019 May 15;21(5):e11854
pubmed: 31094339
Point Care. 2017 Dec;16(4):141-150
pubmed: 29333105
J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25127
pubmed: 30033557
Nat Med. 2019 Jan;25(1):44-56
pubmed: 30617339
J Med Internet Res. 2015 Sep 01;17(9):e213
pubmed: 26330138
JMIR Public Health Surveill. 2016 Aug 04;2(2):e33
pubmed: 27493067
AIDS Care. 2016;28(3):289-93
pubmed: 26444956
AIDS Behav. 2019 Jan;23(1):116-125
pubmed: 30109456
J Int AIDS Soc. 2020 Jan;23(1):e25448
pubmed: 31960589
AIDS Behav. 2019 Nov;23(11):3129-3139
pubmed: 30852728